You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oxaliplatin

Showing 1 - 25 of 821
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunotherapy Gastrict Cancer Trial (Tislelizumab, apatinib, oxaliplatin)

Not yet recruiting
  • Immunotherapy Gastrict Cancer
  • (no location specified)
Jan 17, 2023

Elderly Metastatic Colorectal Cancer Patients Trial in Padua (Capecitabine, Oxaliplatin, Bevacizumab)

Active, not recruiting
  • Elderly Metastatic Colorectal Cancer Patients
  • Padua, Italy
    Istituto Oncologico Veneto IRCCS
Mar 30, 2022

Gastric Cancer Trial in Gyeonggi-do (Oxaliplatin, Capecitabine)

Recruiting
  • Gastric Cancer
  • Gyeonggi-do, Korea, Republic of
    Hallym University Medical Center
Feb 4, 2022

Stage III Colon Cancer Trial in France (Oxaliplatin, Oxaliplatin LBM)

Active, not recruiting
  • Stage III Colon Cancer
  • Oxaliplatin
  • Oxaliplatin LBM
  • Marseille, Bouches Du Rhône, France
  • +10 more
Aug 2, 2022

Gastric Cancer Trial in Beijing (S-1, Trastuzumab, Oxaliplatin)

Completed
  • Gastric Cancer
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences
Aug 14, 2022

Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)

Terminated
Has Results
  • Colorectal Neoplasms
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Dec 30, 2021

Gastric Cancer Trial in Mykolaiv (Docetaxel, Oxaliplatin, Leucovorin)

Active, not recruiting
  • Gastric Cancer
  • Mykolaiv, Ukraine
    Ukrainian Society of Clinical Oncology
Apr 11, 2022

Liver Cancer Trial in France (Oxaliplatin, Irofulven)

Completed
  • Liver Cancer
  • Bordeaux, France
  • +6 more
Nov 24, 2021

Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)

Not yet recruiting
  • Gastric Cancer Stage IV
  • Oxaliplatin
  • +4 more
  • (no location specified)
Apr 1, 2022

Immunotherapy, Gastrict Cancer Trial in Fuzhou (Tislelizumab, Apatinib Mesylate, oxaliplatin)

Recruiting
  • Immunotherapy
  • Gastrict Cancer
  • Fuzhou, China
    Fujian cancer hospital
Jan 23, 2022

Rectal Cancer, Consolidation Trial in São Paulo (Oxaliplatin, 5FU)

Recruiting
  • Rectal Cancer
  • Consolidation
  • São Paulo, SP, Brazil
    Hospital Alemão Oswaldo Cruz
Aug 3, 2021

Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo

Not yet recruiting
  • Colorectal Adenocarcinoma
  • +2 more
  • Trondheim, Trondelag, Norway
  • +2 more
Aug 15, 2022

Metastatic Colorectal Cancer Trial in Herlev (Oxaliplatin, 5-Fluorouracil, Leucovorin)

Withdrawn
  • Metastatic Colorectal Cancer
  • Oxaliplatin
  • +4 more
  • Herlev, Denmark
    Herlev University Hospital, Department of Oncology
Oct 19, 2021

Colon Adenocarcinoma Trial in Sacramento (Carbon C 14 Oxaliplatin, Oxaliplatin)

Completed
Has Results
  • Colon Adenocarcinoma
  • Carbon C 14 Oxaliplatin
  • Oxaliplatin
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Mar 4, 2021

Biliary Tract Tumor Trial in Nanjing (Tislelizumab, Lenvatinib, Oxaliplatin)

Recruiting
  • Biliary Tract Tumor
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
Mar 14, 2022

Gastric Cancer Trial in Jinan (SHR1210, Apatinib, S1)

Recruiting
  • Gastric Cancer
  • Jinan, Shandong, China
    Qilu hospital of Shandong univertisy
Mar 30, 2022

Colorectal Cancer, Peritoneal Metastases Trial in Sweden (5Fluorouracil, Irinotecan, Oxaliplatin)

Recruiting
  • Colorectal Cancer
  • Peritoneal Metastases
  • Gothenburg, Sweden
  • +3 more
Oct 12, 2021

Colorectal Cancer, Appendiceal Cancer, Peritoneal Carcinoma Trial in Salt Lake City (Oxaliplatin, mFOLFIRI)

Terminated
  • Colorectal Cancer
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Sep 21, 2021

Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Docetaxel,

Recruiting
  • Metastatic Gastric Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Guangzhou, Guangdong, China
    The Sixth Affiliated hosipital, Sun Yat-Sen University
Jan 20, 2022

Gastric Cancer, GastroEsophageal Cancer Trial in Beijing (SHR-1210, Capecitabine, Oxaliplatin)

Active, not recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital, Peking University
Aug 24, 2021

Colorectal Tumors, Stomach Tumor, Esophageal Tumors Trial in Cork, Dublin 8 (Lithium, Oxaliplatin, Capecitabine)

Recruiting
  • Colorectal Neoplasms
  • +2 more
  • Cork, Ireland
  • +1 more
Feb 9, 2022

Phase II, Open-label, Parallel 2-arm, Multi-center Trial in Kaohsiung, Taichung, Tainan (Gemcitabine 1000 mg, Nab paclitaxel,

Recruiting
  • Phase II, Open-label, Parallel 2-arm, Multi-center
  • Gemcitabine 1000 mg
  • +4 more
  • Kaohsiung, Taiwan
  • +2 more
Jun 12, 2022

Neuroblastoma Trial in United States (Tolcapone, Oxaliplatin)

Terminated
  • Neuroblastoma
  • Little Rock, Arkansas
  • +8 more
Apr 20, 2022

Metastatic Colorectal Carcinoma, Recurrent Colon Carcinoma, Refractory Colorectal Carcinoma Trial in Livingston, New Brunswick

Recruiting
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Oxaliplatin
  • Trifluridine and Tipiracil Hydrochloride
  • Livingston, New Jersey
  • +1 more
Mar 16, 2022

Colorectal Adenocarcinoma, Oesogastric Trial in France (Trifluridine/Tipiracil, Oxaliplatin)

Recruiting
  • Colorectal Adenocarcinoma
  • Oesogastric
  • Besançon, France
  • +10 more
Jan 28, 2022